This compound is a benzenesulfonyl-substituted pyrrolopyridine primarily used as a pharmaceutical intermediate in the manufacture of kinase inhibitors. Its structure features a chloro and nitro substituent, contributing to its role in research and chemical synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1245649-52-8
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
Pharmaceutical intermediate for kinase inhibitors
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furancarboxaldehyde
Pharmaceutical intermediate for kinase inhibitors
3-Amino-5-(4-phenoxyphenyl)-1H-pyrazole-4-carbonitrile
Pharmaceutical intermediate for kinase inhibitors
4-Chloro-7-(p-toluenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine
Pharmaceutical intermediate for kinase inhibitors
Tert-butyl 2,5-diazaspiro[3.5]nonane-5-carboxylate
Pharmaceutical intermediate
Methyl (alphaR,betaS)-beta-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-hydroxybenzenepropanoate
Pharmaceutical intermediate
(S)-N-(Pyrrolidin-3-yl)acetamide hydrochloride
pharmaceutical intermediate
(R)-N,N-Dimethylpyrrolidin-3-amine hydrochloride
pharmaceutical intermediate
1-(benzenesulfonyl)-4-chloro-5-nitropyrrolo[2,3-b]pyridine
VDNRYINHXTYMIT-UHFFFAOYSA-N
C1=CC=C(C=C1)S(=O)(=O)N2C=CC3=C(C(=CN=C32)[N+](=O)[O-])Cl
—